
Under typical market conditions, this fund is designed to invest at least 80% of its overall assets (including any funds acquired through borrowing) in securities that are either part of its reference index or possess analogous economic attributes. This benchmark index is composed of the equity shares of the 50 leading companies, measured by their publicly traded market capitalization, which are listed on the Shanghai Stock Exchange's Science and Technology Innovation Board, also known as the STAR Board. It operates as a non-diversified fund.
Is KSTR's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

Biotech, China, insurance and healthcare ETFs led June gains as strong earnings, AI optimism and easing geopolitical fears lifted markets.
June has been a month full of excitement in the ETF market. While commercial space and AI infrastructure attracted a significant amount of investor attention, biotechnology exposure comprises four out of the five top-performing equity ETFs as of June 29.

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- KraneShares today announced that its China ETF, the KraneShares China Technology & Semiconductor STAR 50 Index ETF (NYSE: KSTR)*, returned +71.70% year-to-date (YTD) and +131.80% over the past year as of June 30th, 2026.1

KSTR climbs to a fresh 52-week high amid rising optimism that improving U.S.-China relations could lift the Chinese tech stocks.

KraneShares SSE Star Market 50 Index ETF (NYSEARCA:KSTR - Get Free Report)'s stock price traded up 0.8% during trading on Monday. The company traded as high as $19.57 and last traded at $19.53. 78,487 shares changed hands during trading, a decline of 19% from the average session volume of 96,318 shares. The stock had